Literature DB >> 20101720

Neuropathology of Alzheimer's disease.

Daniel P Perl1.   

Abstract

Alois Alzheimer first pointed out that the disease which would later bear his name has a distinct and recognizable neuropathological substrate. Since then, much has been added to our understanding of the pathological lesions associated with the condition. The 2 primary cardinal lesions associated with Alzheimer's disease are the neurofibrillary tangle and the senile plaque. The neurofibrillary tangle consists of abnormal accumulations of abnormally phosphorylated tau within the perikaryal cytoplasm of certain neurons. The senile plaque consists of a central core of beta-amyloid, a 4-kD peptide, surrounded by abnormally configured neuronal processes or neurites. Other neuropathological lesions are encountered in cases of Alzheimer's disease, but the disease is defined and recognized by these 2 cardinal lesions. Other lesions include poorly understood changes such as granulovacuolar degeneration and eosinophilic rodlike bodies (Hirano bodies). The loss of synaptic components is a change that clearly has a significant impact on cognitive function and represents another important morphological alteration. It is important to recognize that distinguishing between Alzheimer's disease, especially in its early stages, and normal aging may be very difficult, particularly if one is examining the brains of patients who died at an advanced old age. It is also noted that instances of pure forms of Alzheimer's disease, in the absence of other coexistent brain disease processes, such as infarctions or Parkinson's disease-related lesions, are relatively uncommon, and this must be taken into account by researchers who employ postmortem brain tissues for research. (c) 2010 Mount Sinai School of Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101720      PMCID: PMC2918894          DOI: 10.1002/msj.20157

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  59 in total

1.  Paired helical filaments in electron microscopy of Alzheimer's disease.

Authors:  M KIDD
Journal:  Nature       Date:  1963-01-12       Impact factor: 49.962

2.  A demonstration of the advantages of immunostaining in the quantification of amyloid plaque deposits.

Authors:  S M Gentleman; C Bruton; D Allsop; S J Lewis; J M Polak; G W Roberts
Journal:  Histochemistry       Date:  1989

3.  A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tangles.

Authors:  B T Hyman; G W Van Hoesen; K Beyreuther; C L Masters
Journal:  Neurosci Lett       Date:  1989-07-03       Impact factor: 3.046

4.  Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Nakazato
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Differences between vascular and plaque core amyloid in Alzheimer's disease.

Authors:  F Prelli; E Castaño; G G Glenner; B Frangione
Journal:  J Neurochem       Date:  1988-08       Impact factor: 5.372

6.  The association of actin with Hirano bodies.

Authors:  J E Goldman
Journal:  J Neuropathol Exp Neurol       Date:  1983-03       Impact factor: 3.685

Review 7.  Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.

Authors:  I G McKeith; E K Perry; R H Perry
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

8.  Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.

Authors:  E Masliah; R D Terry; R M DeTeresa; L A Hansen
Journal:  Neurosci Lett       Date:  1989-08-28       Impact factor: 3.046

9.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Authors:  D W Dickson; J Farlo; P Davies; H Crystal; P Fuld; S H Yen
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

10.  Role of the neuropathology of Alzheimer disease in dementia in the oldest-old.

Authors:  Vahram Haroutunian; Michal Schnaider-Beeri; James Schmeidler; Michael Wysocki; Dushyant P Purohit; Daniel P Perl; Leslie S Libow; Gerson T Lesser; Maria Maroukian; Hillel T Grossman
Journal:  Arch Neurol       Date:  2008-09
View more
  188 in total

1.  Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology.

Authors:  Markus Morawski; Gert Brückner; Carsten Jäger; Gudrun Seeger; Russel T Matthews; Thomas Arendt
Journal:  Brain Pathol       Date:  2012-01-13       Impact factor: 6.508

2.  Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.

Authors:  Charles B Malpas; Michael M Saling; Dennis Velakoulis; Patricia Desmond; Terence J O'Brien
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 3.  PPARα Between Aspirin and Plaque Clearance.

Authors:  Sujyoti Chandra; Avik Roy; Dhruv R Patel; Kalipada Pahan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

Authors:  Sergio T Ferreira; William L Klein
Journal:  Neurobiol Learn Mem       Date:  2011-09-06       Impact factor: 2.877

5.  Mitochondrial Movement and Number Deficits in Embryonic Cortical Neurons from 3xTg-AD Mice.

Authors:  John Z Cavendish; Saumyendra N Sarkar; Mark A Colantonio; Dominic D Quintana; Nadia Ahmed; Brishti A White; Elizabeth B Engler-Chiurazzi; James W Simpkins
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 6.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Authors:  Rui Wang; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  The anteroposterior and primary-to-posterior limbic ratios as MRI-derived volumetric markers of Alzheimer's disease.

Authors:  Adolfo Jiménez-Huete; Susana Estévez-Santé
Journal:  J Neurol Sci       Date:  2017-04-27       Impact factor: 3.181

Review 8.  Peroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier.

Authors:  Juan M Zolezzi; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

9.  Applicability of digital analysis and imaging technology in neuropathology assessment.

Authors:  William D Dunn; Marla Gearing; Yuna Park; Lifan Zhang; John Hanfelt; Jonathan D Glass; David A Gutman
Journal:  Neuropathology       Date:  2015-11-18       Impact factor: 1.906

10.  Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.

Authors:  Erika Chung; Yong Ji; Yanjie Sun; Richard J Kascsak; Regina B Kascsak; Pankaj D Mehta; Stephen M Strittmatter; Thomas Wisniewski
Journal:  BMC Neurosci       Date:  2010-10-14       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.